Canada’s pharma sector can benefit from America’s terrible corporate tax code

Unfortunately, the Canadian pharmaceutical company most discussed these days is Valeant Pharmaceuticals International, Inc., headquartered in the Montreal suburbs. Criticized for eye-popping price hikes for it’s medicines, and embroiled in boardroom drama, Valeant is not really a poster child for Canadian medicines.Nevertheless, innovative Canadian drug-makers should be able to exploit

Vist The Fraser Institute to read the complete article